| pubmed-article:7869122 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7869122 | lifeskim:mentions | umls-concept:C0085140 | lld:lifeskim |
| pubmed-article:7869122 | lifeskim:mentions | umls-concept:C1820158 | lld:lifeskim |
| pubmed-article:7869122 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:7869122 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:7869122 | pubmed:dateCreated | 1995-3-29 | lld:pubmed |
| pubmed-article:7869122 | pubmed:abstractText | The FORSE-1 monoclonal antibody (mAb) was generated using a strategy designed to produce mAbs against neuronal cell surface antigens that might be regulated by regionally restricted transcription factors in the developing CNS. To determine whether FORSE-1 has a labeling pattern similar to that of known transcription factors, the expression of BF-1 and Dlx-2 was examined by in situ hybridization on sections serial to those labeled with FORSE-1. We find a striking overlap between BF-1 and FORSE-1 in the telencephalon; both are expressed in the lateral but not the medial walls of the telencephalon, and the boundaries of expression are apparently identical. FORSE-1 staining is detected prior to BF-1 expression in the neural tube, however. FORSE-1 and Dlx-2 have very different patterns of expression in the forebrain, suggesting that regulation by Dlx-2 cannot by itself explain the distribution of FORSE-1. However, they share some sharp boundaries in the diencephalon. In addition, FORSE-1 identifies some previously unknown boundaries in the developing forebrain. These results indicate that a new cell surface marker can be used to subdivide the embryonic telencephalon and diencephalon into regions smaller than previously described, providing necessary complexity to the developmental patterning in the forebrain. | lld:pubmed |
| pubmed-article:7869122 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7869122 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7869122 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7869122 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7869122 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7869122 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7869122 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7869122 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7869122 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7869122 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7869122 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7869122 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7869122 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7869122 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:7869122 | pubmed:issn | 0270-6474 | lld:pubmed |
| pubmed-article:7869122 | pubmed:author | pubmed-author:PattersonP... | lld:pubmed |
| pubmed-article:7869122 | pubmed:author | pubmed-author:ToleSS | lld:pubmed |
| pubmed-article:7869122 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7869122 | pubmed:volume | 15 | lld:pubmed |
| pubmed-article:7869122 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7869122 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7869122 | pubmed:pagination | 970-80 | lld:pubmed |
| pubmed-article:7869122 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:7869122 | pubmed:meshHeading | pubmed-meshheading:7869122-... | lld:pubmed |
| pubmed-article:7869122 | pubmed:meshHeading | pubmed-meshheading:7869122-... | lld:pubmed |
| pubmed-article:7869122 | pubmed:meshHeading | pubmed-meshheading:7869122-... | lld:pubmed |
| pubmed-article:7869122 | pubmed:meshHeading | pubmed-meshheading:7869122-... | lld:pubmed |
| pubmed-article:7869122 | pubmed:meshHeading | pubmed-meshheading:7869122-... | lld:pubmed |
| pubmed-article:7869122 | pubmed:meshHeading | pubmed-meshheading:7869122-... | lld:pubmed |
| pubmed-article:7869122 | pubmed:meshHeading | pubmed-meshheading:7869122-... | lld:pubmed |
| pubmed-article:7869122 | pubmed:meshHeading | pubmed-meshheading:7869122-... | lld:pubmed |
| pubmed-article:7869122 | pubmed:meshHeading | pubmed-meshheading:7869122-... | lld:pubmed |
| pubmed-article:7869122 | pubmed:meshHeading | pubmed-meshheading:7869122-... | lld:pubmed |
| pubmed-article:7869122 | pubmed:meshHeading | pubmed-meshheading:7869122-... | lld:pubmed |
| pubmed-article:7869122 | pubmed:meshHeading | pubmed-meshheading:7869122-... | lld:pubmed |
| pubmed-article:7869122 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7869122 | pubmed:articleTitle | Regionalization of the developing forebrain: a comparison of FORSE-1, Dlx-2, and BF-1. | lld:pubmed |
| pubmed-article:7869122 | pubmed:affiliation | Division of Biology, California Institute of Technology, Pasadena 91125. | lld:pubmed |
| pubmed-article:7869122 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7869122 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:7869122 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7869122 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7869122 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7869122 | lld:pubmed |
